GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing-March 2024-www.financetom.com

GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing

May 16, 2024 12:44 AM

03:21 AM EDT, 05/16/2024 (MT Newswires) -- Jan Makela, Chief Executive Officer, Imaging, on May 13, 2024, sold 87,182 shares in GE HealthCare Technologies ( GEHC ) for $7,109,427. Following the Form 4 filing with the SEC, Makela has control over a total of 63,348 shares of the company, with 63,348 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1932393/000162828024023668/xslF345X03/wk-form4_1715814910.xml

Price: 81.67, Change: -0.24, Percent Change: -0.29

Previous page： Arthur J. Gallagher's quarterly profit rises on higher commissions and fees Next page： Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Arthur J. Gallagher's quarterly profit rises on higher commissions and fees

Aug 1, 2025

(Reuters) -Arthur J. Gallagher reported a rise in second-quarter profit on Thursday, supported by strong insurance spending that led to higher commissions and fees for the company. Insurance brokerages, which act as intermediaries by assisting customers in selecting suitable plans for their needs, do not directly sell policies. Insurance spending stayed strong in the quarter as individuals and businesses sought...

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Aug 1, 2025

Shares of Novavax Inc ( NVAX ) are trading lower Friday morning, appearing to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna Inc ( MRNA ) reported disappointing second-quarter financial results and cut its full-year forecast. What To Know: Moderna ( MRNA ) announced on Friday a significant second-quarter loss of $2.12 per share, substantially missing...

Church & Dwight Tops Q2 Estimates Despite Orajel Recall Costs

Aug 1, 2025

Church & Dwight Company, Inc. ( CHD ) , on Friday, reported second-quarter results with adjusted earnings per share of 94 cents. The household products maker beat the analyst consensus estimate of 85 cents. Quarterly sales of $1.51 billion outpaced the Street view of $1.48 billion. Net sales declined 0.3%, with domestic sales down 1.4%, international sales up 5.3%, and...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...